Need Help?
Contact Us

IT TAKES COLLABORATION TO MAKE SCIENCE MORE MEANINGFUL

  • News Releases

    Boston Scientific to Participate in the Cowen and Company 39th Annual Healthcare Conference

    MARLBOROUGH, Mass., Feb. 27, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in the Cowen and Company 39th Annual Healthcare Conference on Wednesday, March 13, 2019 in Boston.

    Boston Scientific Corporation (PRNewsFoto/Boston Scientific Corporation) (PRNewsFoto/Boston Scientific Corporation)

    Dan Brennan, executive vice president and chief financial officer, and Lindsay Fish, director, Investor Relations, will participate in a 30-minute question-and-answer session with the host analyst beginning at approximately 8:40 a.m. EDT.  A live webcast of the question-and-answer session will be available on the Investor Relations section of the Boston Scientific website at investors.bostonscientific.com.

    A replay of the webcast will be accessible at investors.bostonscientific.comhttp://www.bostonscientific.com/investors beginning approximately one hour following the completion of the event.

    About Boston Scientific 
    Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

    CONTACTS


    Media:                                           

    Investors:

    Kate Haranis                                 

    Susie Lisa, CFA

    508-683-6585 (office)                   

    508-683-5565 (office)

    Media Relations                              

    Investor Relations

    Boston Scientific Corporation          

    Boston Scientific Corporation

    Kate.Haranis@bsci.com                  

    BSXInvestorRelations@bsci.com

     

    SOURCE Boston Scientific Corporation